Prader-Willi syndrome and growth hormone defciency

JCRPE Journal of Clinical Research in Pediatric Endocrinology

Volumn 6, Issue 2, 2014, Pages 62-67

  Aycan, Zehra ^a,b   Baş, Veysel Nijat ^c  

^a Childrens' Education and Research Hospital   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^c Kayseri Training and Education Hospital of Medicine   (Turkey)

Author keywords

Growth hormone deficiency; Growth hormone treatment; Prader Willi syndrome

Indexed keywords

CHOLESTEROL; CORTICOTROPIN; GROWTH HORMONE; HYDROCORTISONE; LEVOTHYROXINE; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; HUMAN GROWTH HORMONE;

ADENOTONSILLAR HYPERTROPHY; ADRENAL INSUFFICIENCY; ARTICLE; BODY COMPOSITION; BONE DENSITY; COGNITION; DIET; DISORDERS OF CARBOHYDRATE METABOLISM; DRUG DOSE INCREASE; GROWTH HORMONE DEFICIENCY; GROWTH RATE; GROWTH RETARDATION; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; POLYSOMNOGRAPHY; PRADER WILLI SYNDROME; RESPIRATORY TRACT DISEASE; SLEEP DISORDERED BREATHING; SUDDEN DEATH; UPPER RESPIRATORY TRACT OBSTRUCTION; ADOLESCENT; ADULT; CHILD; COGNITION DISORDERS; COMPLICATION; DEFICIENCY; DIET THERAPY; DRUG EFFECTS; FEMALE; INFANT; MALE; METABOLISM; NEWBORN; OBESITY, MORBID; PATHOPHYSIOLOGY; PRADER-WILLI SYNDROME; PRESCHOOL CHILD;

ADOLESCENT; ADULT; BODY COMPOSITION; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; FEMALE; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; MALE; OBESITY, MORBID; PRADER-WILLI SYNDROME;

EID: 84902304729     PISSN: 13085727     EISSN: 13085735     Source Type: Journal    
DOI: 10.4274/jcrpe.1228     Document Type: Article

References (38)

1. Prader A, Labhart A, Willi A. Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myotonie artigen zustand im neugeborenenalter. Schweiz Med Wochen 1956;86:1260.
2. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med 2012;14:10-26.
3. Butler MG. Prader-Willi syndrome: obesity due to genomic imprinting. Curr Genomics 2011;12:204-215.
4. Goldstone A P, Holland AJ, Hauffa B P, Hokken-Koelega AC, Tauber M; speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab 2008;93:4183-4197. Epub 2008 Aug 12
5. McCandless SE; Committee on Genetics. Clinical report-health supervision for children with Prader-Willi syndrome. Pediatrics 2011;127:195-204. Epub 2010 Dec 27
6. Diene G, Mimoun E, Feigerlova E, Caula S, Molinas C, Grandjean H, Tauber M; French Reference Centre for PWS. Endocrine disorders in children with Prader-Willi syndrome-data from 142 children of the French database. Horm Res Paediatr 2010;74:121-128. Epub 2010 Apr 15
7. Emerick JE, Vogt KS. Endocrine manifestations and management of Prader-Willi syndrome. Int J Pediatr Endocrinol 2013;2013:14.
8. Bekx M T, Carrel AL, Shriver TC, Li Z, Allen DB. Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi syndrome. J Pediatr 2003;143:372-376.
9. Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS; 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants. Growth Hormone Research Society work shop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 2013;98:1072-1087. Epub 2013 Mar 29
10. Burman P, Ritzén EM, Lindgren AC. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 2001;22:787-799.
11. Eiholzer U, Stutz K, Weinmann C, Torresani T, Molinari L, Prader A. Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome. Eur J Pediatr 1998;157:890-893.
12. Grugni G, Crinò A, Pagani S, Meazza C, Buzi F, De Toni T, Gargantini L, Pilotta A, Pozzan GB, Radetti G, Ragusa L, Salvatoni A, Sartorio A, Bozzola M; Genetic Obesity Study Group, Italian Society of Pediatric Endocrinology and Diabetology. Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome. J Pediatr Endocrinol Metab 2011;24:477-481.
13. Carrel AL, Myers SE, Whitman B Y, Eickhoff J, Allen DB. Long-Term Growth Hormone Therapy Changes the Natural History of Body Composition and Motor Function in Children with Prader-Willi Syndrome. J Clin Endocrinol Metab 2010;95:1131-1136. Epub 2010 Jan 8
14. Fillion M, Deal C, Van Vliet G. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willis syndrome. J Pediatr 2009;154:230-233. Epub 2008 Sep 23
15. Siemensma E P, Tummers de Lind van Wijngaarden R F, Festen DA, Troeman ZC, van Alfen van der Velden AA, Otten BJ, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Oostdijk W, Bocca G, Mieke Houdijk EC, van Trotsenburg AS, Hoorweg-Nijman JJ, van Wieringen H, Vreuls RC, Jira PE, Schroor EJ, van Pinxteren-Nagler E, Willem Pilon J, Lunshof LB, Hokken-Koelega AC. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. J Clin Endocrinol Metab 2012;97:2307-2314. Epub 2012 Apr 16
16. Feigerlová E, Diene G, Oliver I, Gennero I, Salles J P, Arnaud C, Tauber M. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment. J Clin Endocrinol Metab 2010;95:4600-4608.
17. van Nieuwpoort IC, Sinnema M, Castelijns JA, Twisk JW, Curfs LM, Drent ML. The GH/IGF-I axis and pituitary function and size in adults with Prader-Willi syndrome. Horm Res Paediatr 2011;75:403-411. Epub 2011 Jan 27
18. Growth Hormone and Prader Willi Syndrome. 2th ed. Editor Donald G Goranson 2011:7-8.
19. De Lind van Wijngaarden R F, Siemensma E P, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome. J Clin Endocrinol Metab 2009;94:4205-4215. Epub 2009 Oct 16
20. Höybye C, Thorén M, Böhm B. Cognitive emotional, physicaland social effects of growth hormone treatment in adults with Prader-Willi syndrome. J Intellect Disabil Res 2005;49:245-252.
21. Mogul HR, Lee PD, Whitman B Y, Zipf WB, Frey M, Myers S, Cahan M, Pinyerd B, Southren AL. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat and serum triiodothyronine without glucose impairment: results from the United States multicenter trial. J Clin Endocrinol Metab 2008;93:1238-1245. Epub 2008 Jan 22
22. Lee PD, Wilson DM, Rountree L, Hintz RL, Rosenfeld RG. Linear growth response to exogenous growth hormone in Prader-Willi syndrome. Am J Med Genet 1987;28:865-871.
23. Myers SE, Whitman B Y, Carrel AL, Moerchen V, Bekx M T, Allen DB. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 2007;143:443-448.
24. Festen DA, Wevers M, Lindgren AC, Böhm B, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Clin Endocrinol (Oxf) 2008;68:919-925. Epub 2007 Nov 19
25. Bakker NE, Kuppens RJ, Siemensma E P, Tummers de Lind van Wijngaarden R F, Festen DA, Bindels-de Heus GC, Bocca G, Haring DA, Hoorweg-Nijman JJ, Houdijk EC, Jira PE, Lunshof L, Odink RJ, Oostdijk W, Rotteveel J, Schroor EJ, Van Alfen AA, Van Leeuwen M, Van Pinxteren-Nagler E, Van Wieringen H, Vreuls RC, Zwaveling-Soonawala N, de Ridder MA, Hokken-Koelega AC. Eight years of growth hormone treatment in children with prader-willi syndrome: maintaining the positive effects. J Clin Endocrinol Metab 2013;98:4013-4022. Epub 2013 Sep 3
26. Angulo MA, Castro-Magana M, Lamerson M, Arguello R, Accacha S, Khan A. Final adult height in children with Prader-Willi syndrome with and without human growth hormone treatment. Am J Med Genet A 2007;143:1456-1461.
27. Nagai T, Obata K, Tonoki H, Temma S, Murakami N, Katada Y, Yoshino A, Sakazume S, Takahashi E, Sakuta R, Niikawa N. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 2005;136:45-48.
28. Tauber M, Diene G, Molinas C, Hébert M.Review of 64 cases of death in children with Prader-Willi syndrome (PWS). Am J Med Genet A 2008;146:881-887.
29. De Lind van Wijngaarden R F, Otten BJ, Festen DA, Joosten K F, de Jong FH, Sweep FC, Hokken-Koelega AC. High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. J Clin Endocrinol Metab 2008;93:1649-1654. Epub 2008 Feb 26
30. De Lind van Wijngaarden R F, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, van Leeuwen M, Haring DA, Bocca G, Mieke Houdijk EC, Hokken-Koelega AC. Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial. J Clin Endocrinol Metab 2009;94:3763-3771. Epub 2009 Jul 21
31. De Lind van Wijngaarden R F, de Klerk LW, Festen DA, Duivenvoorden HJ, Otten BJ, Hokken-Koelega AC. Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome. J Clin Endocrinol Metab 2009;94:1274-1280. Epub 2009 Jan 21
32. Grugni G, Crinò A, Bosio L, Corrias A, Cuttini M, De Toni T, Di Battista E, Franzese A, Gargantini L, Greggio N, Iughetti L, Livieri C, Naselli A, Pagano C, Pozzan G, Ragusa L, Salvatoni A, Trifirò G, Beccaria L, Bellizzi M, Bellone J, Brunani A, Cappa M, Caselli G, Cerioni V, Delvecchio M, Giardino D, Iannì F, Memo L, Pilotta A, Pomara C, Radetti G, Sacco M, Sanzari A, Sartorio A, Tonini G, Vettor R, Zaglia F, Chiumello G; Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology (ISPED). The Italian National Survey for Prader-Willi syndrome: an epidemiologic study. Am J Med Genet A 2008;146:861-872.
33. Sode-Carlsen R, Farholt S, Rabben K F, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C. One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study. J Clin Endocrinol Metab 2010;95:4943-4950. Epub 2010 Aug 11
34. Höybye C, Hilding A, Jacobsson H, Thorén M. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome. Clin Endocrinol (Oxf) 2003;58:653-661.
35. Bakker B, Maneatis T, Lippe B. Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005;63:33-39). Horm Res 2007;67:203-204. Epub 2006 Dec 12
36. Nordmann Y, Eiholzer U, l'Allemand D, Mirjanic S, Markwalder C. Sudden death of an infant with Prader-Willi syndrome not a unique case? Biol Neonate 2002;82:139-142.
37. Eiholzer U, Nordmann Y, L'Allemand D.Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. A case report. Horm Res 2002;58(Suppl 3):24-26.
38. Van Vliet G, Deal CL, Crock PA, Robitaille Y, Oligny LL. Sudden death in growth hormone-treated children with Prader-Willi syndrome. J Pediatr 2004;144:129-131.